ProstAsure

ProstAsure®

Urology A computer-assisted test that discerns subtle changes in biochemical activity among groups of highly relevant biomarkers–eg, PSA, which is said to be 85% sensitive for prostate CA still confined within the prostatic capsule, thus leading to earlier diagnosis, treatment, cure. See Prostate cancer.
References in periodicals archive ?
Thus, there were fewer false-positive values for the Prostasure index than with fPSA.
Using the ProstAsure index may add diagnostic value when PSA levels are between 4 and 10 ng/mL.
Effectiveness of ProstAsure in detecting PCA and BPH in men age 50 and older.
The ability of the ProstAsure index to identify patients with low cancer volumes and high potential for cure [abstract].
ProstAsure has been shown clinically to be 85% accurate in detecting cancer before it expands beyond the prostate.
Cooperative use of the Internet by Medical Industries Australia and Horus will make possible the availability of ProstAsure to all men aged 40 and over throughout Australia and New Zealand.
The ProstAsure test has been clinically shown to be 90 percent accurate in diagnosing prostate cancer.
Greater accuracy with ProstAsure significantly enhances diagnostic capabilities available to physicians, thus helping to save the lives of more patients through early detection and treatment.